Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy

Vaccine

Volumn 30, Issue 5, 2012, Pages 825-829

  López, Patricia ^a,b   González Rodríguez, Irene ^b   Sánchez, Borja ^b   Gueimonde, Miguel ^b   Margolles, Abelardo ^b   Suárez, Ana ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

Author keywords

Adjuvant; Allergen specific immunotherapy; Bifidobacteria; Probiotics; Regulatory T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BIFIDOBACTERIUM BIFIDUM; CD25+ T LYMPHOCYTE; CELL FRACTIONATION; DENDRITIC CELL; IMMUNOTHERAPY; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ALLERGENS; BIFIDOBACTERIUM; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; SECRETORY VESICLES; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855444412     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.115     Document Type: Article

References (21)

1. Kalliomäki M., Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003, 3:15-20.
2. Foligne B., Zoumpopoulou G., Dewulf J., Ben Younes A., Chareyre F., Sirard J-C., et al. A key role of dendritic cells in probiotic functionality. PLoS ONE 2007, 2:e313.
3. López P., Gueimonde M., Margolles A., Suárez A. Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol 2010, 138:157-165.
4. Cottrez F., Hurst S.D., Coffman R.L., Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000, 165:4848-4853.
5. Akdis M., Akdis C. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007, 119:780-789.
6. de Roock S., van Elk M., van Dijk M.E.A., Timmerman H.M., Rijkers G.T., Prakken B.J., et al. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 2010, 40:103-110.
7. Prescott S.L., Björkstén B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007, 120:255-262.
8. Lopez P, Gonzalez-Rodriguez I, Gueimonde M, Margolles A, Suarez A. Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity. PLoS One 2011;6:e24776.
9. Sánchez B., de los Reyes-Gavilán C.G., Margolles A. The F1F0-ATPase of Bifidobacterium animalis is involved in bile tolerance. Environ Microbiol 2006, 8:1825-1833.
10. Repa A., Grangette C., Daniel C., Hochreiter R., Hoffmann-Sommergruber K., Thalhamer J., et al. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003, 22:87-95.
11. Schabussova I., Wiedermann U. Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases. Curr Opin Allergy Clin Immunol 2008, 8:557-564.
12. Leuschner R.G.K., Robinson T.P., Hugas M., Cocconcelli P.S., Richard-Forget F., Klein G., et al. Qualified presumption of safety (QPS): a generic risk assessment approach for biological agents notified to the European Food Safety Authority (EFSA). Trends Food Sci Technol 2010, 21:425-435.
13. Niers L.E.M., Hoekstra M.O., Timmerman H.M., van Uden N.O., de Graaf P.M.A., Smits H.H., et al. Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clin Exp Immunol 2007, 149:344-352.
14. Baba N., Samson S., Bourdet-Sicard R., Rubio M., Sarfati M. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol 2008, 84:468-476.
15. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M.M., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005, 115:1260-1267.
16. Hacini-Rachinel F., Gheit H., Le Luduec J-B., Dif F., Nancey S., Kaiserlian D. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS ONE 2009, 4:e4903.
17. Zhang L-L., Chen X., Zheng P-Y., Luo Y., Lu G-F., Liu Z-Q., et al. Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. J Gastroenterol Hepatol 2010, 25:928-934.
18. Van Overtvelt L., Moussu H., Horiot S., Samson S., Lombardi V., Mascarell L., et al. Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 2010, 28:2986-2992.
19. Van Overtvelt L., Lombardi V., Razafindratsita A., Saint-Lu N., Horiot S., Moussu H., et al. IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol 2008, 145:152-162.
20. Nieves W., Asakrah S., Qazi O., Brown K.A., Kurtz J., Aucoin D.P., et al. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine 2011, 29(46):8381-8389. (Epub 24 August 2011).
21. Chen D.J., Osterrieder N., Metzger S.M., Buckles E., Doody A.M., DeLisa M.P., et al. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc Natl Acad Sci USA 2010, 107:3099-3104.